Marcus Muehlbauer, M.D.

Marcus Muehlbauer, M.D., Ph.D. - Background

(352) 273-9400

Request an Appointment


Marcus Muehlbauer received his initial clinical and research training (MD PhD), under the mentorship of Dr. Claus Hellerbrand MD, at the University of Regensburg, Germany. From 2001 through 2006 he investigated the role of inflammation in the development of hepatocellular carcinomas in chronic liver disease. In 2006 he became interested in the role of the microbiome in inflammatory bowel disease and especially colitis-associated colon cancer and joined the laboratory of Dr. Christian Jobin. He was also accepted into the ABIM research pathway for Gastroenterology at the University of North Carolina at Chapel Hill for clinical and research training specialized in inflammatory bowel disease. He joined faculty at UNC in Fall 2014 and came to UF in June 2015. Dr. Muehlbauer’s laboratory is currently investigating how the microbiome and microbial products affect wound healing through modulation of the intestinal stem cell niche in necrotizing enterocolitis, colitis and colitis-associated colon cancer.


Residency - Gastroenterology
UNC Hospitals

Other Program - Gastroenterology
UNC Hospitals

Residency - Gastroenterology
University of Regensburg

Medical Degree
Universitaet Regenburg

Board Certification

  • Internal Medicine - American Board of Internal Medicine